Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
5.
Leukemia ; 30(5): 1126-32, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26710883

RESUMO

Essential thrombocythemia (ET) is currently diagnosed either by the British Committee of Standards in Haematology (BCSH) criteria that are predominantly based on exclusion and not necessarily on bone marrow (BM) morphology, or the World Health Organization (WHO) criteria that require BM examination as essential criterion. We studied the morphological and clinical features in patients diagnosed according either to the BCSH (n=238) or the WHO guidelines (n=232). The BCSH-defined ET cohort was re-evaluated by applying the WHO classification. At presentation, patients of the BCSH group showed significantly higher values of serum lactate dehydrogenase and had palpable splenomegaly more frequently. Following the WHO criteria, the re-evaluation of the BCSH-diagnosed ET cohort displayed a heterogeneous population with 141 (59.2%) ET, 77 (32.4%) prefibrotic primary myelofibrosis (prePMF), 16 (6.7%) polycythemia vera and 4 (1.7%) primary myelofibrosis. Contrasting WHO-confirmed ET, the BCSH cohort revealed a significant worsening of fibrosis-free survival and prognosis. As demonstrated by the clinical data and different outcomes between WHO-diagnosed ET and prePMF, these adverse features were generated by the inadvertent inclusion of prePMF to the BCSH group. Taken together, the diagnosis of ET without a scrutinized examination of BM biopsy specimens will generate a heterogeneous cohort of patients impairing an appropriate clinical management.


Assuntos
Medula Óssea/patologia , Guias de Prática Clínica como Assunto/normas , Trombocitemia Essencial/diagnóstico , Academias e Institutos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Exame de Medula Óssea , Humanos , L-Lactato Desidrogenase/sangue , Pessoa de Meia-Idade , Prognóstico , Esplenomegalia , Organização Mundial da Saúde , Adulto Jovem
6.
J Clin Microbiol ; 52(6): 2039-45, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24671798

RESUMO

Galactomannan detection in bronchoalveolar lavage (BAL) fluid samples (GM test) is currently considered the gold standard test for diagnosing invasive pulmonary aspergillosis (IPA). The limitations, however, are the various turnaround times and availability of testing. We compared the performance of GM testing with that of conventional culture, an Aspergillus lateral-flow-device (LFD) test, a beta-d-glucan (BDG) test, and an Aspergillus PCR assay by using BAL fluid samples from immunocompromised patients. A total of 78 BAL fluid samples from 78 patients at risk for IPA (74 samples from Graz and 4 from Mannheim) collected between December 2012 and May 2013 at two university hospitals in Austria and Germany were included. Three patients had proven IPA, 14 probable IPA, and 17 possible IPA, and 44 patients had no IPA. The diagnostic accuracies of the different methods for probable/proven IPA were evaluated. The diagnostic odds ratios were the highest for the GM, PCR, and LFD tests. The sensitivities for the four methods (except culture) were between 70 and 88%. The combination of the GM (cutoff optical density index [ODI], >1.0) and LFD tests increased the sensitivity to 94%, while the combination of the GM test (>1.0) and PCR resulted in 100% sensitivity (specificity for probable/proven IPA, 95 to 98%). The performance of conventional culture was limited by low sensitivity, while that of the BDG test was limited by low specificity. We evaluated established and novel diagnostic methods for IPA and found that the Aspergillus PCR, LFD, and GM tests were the most useful methods for diagnosing the disease by using BAL fluid samples. In particular, the combination of the GM test and PCR or, if PCR is not available, the LFD test, allows for sensitive and specific diagnosis of IPA.


Assuntos
Antígenos de Fungos/análise , Aspergillus/isolamento & purificação , Líquido da Lavagem Broncoalveolar/microbiologia , DNA Fúngico/análise , Aspergilose Pulmonar Invasiva/diagnóstico , Técnicas Microbiológicas/métodos , Adulto , Idoso , Aspergillus/química , Aspergillus/crescimento & desenvolvimento , Áustria , Líquido da Lavagem Broncoalveolar/química , Cromatografia de Afinidade/métodos , Feminino , Galactose/análogos & derivados , Alemanha , Glucanos/análise , Hospitais Universitários , Humanos , Hospedeiro Imunocomprometido , Masculino , Mananas/análise , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase/métodos , Estudos Prospectivos , Estudos Retrospectivos , Sensibilidade e Especificidade , Adulto Jovem
7.
Minerva Anestesiol ; 79(4): 419-33, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23419334

RESUMO

Patients with neuromuscular disorders are at high risk of intraoperative and postoperative complications. General anesthesia in these patients may exacerbate respiratory and cardiovascular failure due to a marked sensitivity to several anesthetic drugs. Moreover, succinylcholine and halogenated agents can trigger life-threatening reactions, such as malignant hyperthermia, rhabdomyolysis and severe hyperkalemia. Therefore, regional anesthesia should be used whenever possible. If general anesthesia is unavoidable, special precautions must be taken. In particular, for patients at increased risk of respiratory complications (i.e., postoperative atelectasis, acute respiratory failure, nosocomial infections), noninvasive ventilation associated with aggressive airway clearance techniques can successfully treat upper airway obstruction, hypoventilation and airway secretion retention, avoiding prolonged intubation and tracheotomy. Anesthesia and perioperative management of patients with neuromuscular disorders are described in this article. To grade the strength of recommendations and the quality of evidence we adopted the GRADE approach. In case of low-quality evidence, these recommendations represent the collective opinion of the expert panel.


Assuntos
Anestesia/normas , Doenças Neuromusculares/terapia , Assistência Perioperatória/normas , Manuseio das Vias Aéreas , Testes de Função Cardíaca , Humanos , Cuidados Intraoperatórios , Exame Neurológico , Assistência ao Paciente , Cuidados Pós-Operatórios , Cuidados Pré-Operatórios , Testes de Função Respiratória
9.
Leukemia ; 26(8): 1842-9, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22388727

RESUMO

RAF kinase inhibitor protein (RKIP) is a negative regulator of the RAS-mitogen-activated protein kinase/extracellular signal-regulated kinase signaling cascade. We investigated its role in acute myeloid leukemia (AML), an aggressive malignancy arising from hematopoietic stem and progenitor cells (HSPCs). Western blot analysis revealed loss of RKIP expression in 19/103 (18%) primary AML samples and 4/17 (24%) AML cell lines but not in 10 CD34+ HSPC specimens. In in-vitro experiments with myeloid cell lines, RKIP overexpression inhibited cellular proliferation and colony formation in soft agar. Analysis of two cohorts with 103 and 285 AML patients, respectively, established a correlation of decreased RKIP expression with monocytic phenotypes. RKIP loss was associated with RAS mutations and in transformation assays, RKIP decreased the oncogenic potential of mutant RAS. Loss of RKIP further related to a significantly longer relapse-free survival and overall survival in uni- and multivariate analyses. Our data show that RKIP is frequently lost in AML and correlates with monocytic phenotypes and mutations in RAS. RKIP inhibits proliferation and transformation of myeloid cells and decreases transformation induced by mutant RAS. Finally, loss of RKIP seems to be a favorable prognostic parameter in patients with AML.


Assuntos
Regulação Leucêmica da Expressão Gênica , Leucemia Mieloide Aguda/genética , Proteína de Ligação a Fosfatidiletanolamina/metabolismo , Diferenciação Celular/genética , Linhagem Celular Tumoral , Proliferação de Células , Transformação Celular Neoplásica/genética , Genes ras , Humanos , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/mortalidade , Monócitos/citologia , Monócitos/metabolismo , Mutação , Células Mieloides/metabolismo , Proteína de Ligação a Fosfatidiletanolamina/deficiência , Proteína de Ligação a Fosfatidiletanolamina/genética , Prognóstico
10.
Minerva Anestesiol ; 77(9): 892-901, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21878871

RESUMO

BACKGROUND: To date, few studies have been published regarding the number of children in Italy who require long-term mechanical ventilation (LTV) and their underlying diagnoses, ventilatory needs and hospital discharge rate. METHODS: A preliminary national postal survey was conducted and identified 535 children from 57 centers. Detailed data were then obtained for 378 children from 30 centers. RESULTS: The estimated prevalence in Italy of this population was 4.3/100000. The majority of children (72.2%) were followed in pediatric units. The primary physicians who cared for these patients were either pediatric intensivists or pediatric pulmonologists. Neurological patients (78.2% of cases) represented the principal disorder category. 57.2% of the patients were non-invasively ventilated, with a nasal mask being the most common interface (85% of cases). The presence of clinical symptoms that were associated with abnormal findings on diagnostic testing was the primary indication for ventilatory support, whereas weaning failure was the primary indication for tracheotomy. Invasive ventilation was significantly related to younger age, longer daily hours on ventilation and cerebral palsy. Ventilatory modes with guaranteed minimal tidal volume were more often used in patients with tracheotomy. Despite their age, illness severity and need for technological care, 98% of the study population were successfully home discharged. CONCLUSION: Managing pediatric home LTV requires tremendous effort on the part of the patient's family and places a significant strain on community financial resources. In particular, neurological patients require more health care than patients in other categories. To further improve the quality of care for these patients, it is essential to establish a dedicated national database.


Assuntos
Respiração Artificial , Adolescente , Fatores Etários , Criança , Pré-Escolar , Interpretação Estatística de Dados , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Lactente , Recém-Nascido , Itália , Modelos Logísticos , Masculino , Testes de Função Respiratória , Inquéritos e Questionários , Traqueostomia/estatística & dados numéricos , Desmame do Respirador
11.
Bone Marrow Transplant ; 46(12): 1540-4, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21860429

RESUMO

Therapy-related myeloid neoplasms (t-MNs) are severe long-term consequences of cytotoxic treatments for a primary, often, malignant disorder. So far, the majority of patients eligible for transplantation have undergone myeloablative allo haematopoietic SCT (HSCT) as a potentially curative treatment, but it has been associated with high transplantation-related mortality (TRM) rates. In this retrospective study, we analysed the outcome of patients with t-MNs undergoing HSCT with reduced-intensity conditioning (RIC). Of 55 patients, seen at a single centre over a 10-year period, 17 underwent RIC HSCT with related or unrelated donors. The estimated overall survival was 53% at 1 year and 47% at 3 years, and disease-free survival was 47% at 1 year. At 1 year, the cumulative incidence of relapse and TRM were 24% and 30%, respectively. Of five patients with active primary neoplasms who underwent transplantation, two are alive beyond 1 year and show CR of both t-MNs and the primary malignancy. These data indicate that RIC HSCT is an encouraging approach for patients with t-MNs. The issue of primary malignancies not being in remission at the time of transplantation should be explored in further studies.


Assuntos
Neoplasias Hematológicas/mortalidade , Neoplasias Hematológicas/terapia , Transplante de Células-Tronco Hematopoéticas , Condicionamento Pré-Transplante , Adulto , Idoso , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Taxa de Sobrevida , Fatores de Tempo , Transplante Homólogo
12.
Pediatr Pulmonol ; 46(6): 566-72, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21560263

RESUMO

BACKGROUND: Improved technology, as well as professional and parental awareness, enable many ventilator-dependent children to live at home. However, the profile of this growing population, the quality and adequacy of home care, and patients' needs still require thorough assessment. OBJECTIVES: To define the characteristics of Italian children receiving long-term home mechanical ventilation (HMV) in Italy. METHODS: A detailed questionnaire was sent to 302 National Health Service hospitals potentially involved in the care of HVM in children (aged <17 years). Information was collected on patient characteristics, type of ventilation, and home respiratory care. RESULTS: A total of 362 HMV children was identified. The prevalence was 4.2 per 100,000 (95% CI: 3.8-4.6), median age was 8 years (interquartile range 4-14), median age at starting mechanical ventilation was 4 years (1-11), and 56% were male. The most frequent diagnostic categories were neuromuscular disorders (49%), lung and upper respiratory tract diseases (18%), hypoxic (ischemic) encephalopathy (13%), and abnormal ventilation control (12%). Medical professionals with nurses (for 62% of children) and physiotherapists (20%) participated in the patients' discharge from hospital, though parents were the primary care giver, and in 47% of cases, the sole care giver. Invasive ventilation was used in 41% and was significantly related to young age, southern regional residence, longer time spent under mechanical ventilation, neuromuscular disorders, or hypoxic (ischemic) encephalopathy. CONCLUSIONS: Care and technical assistance of long-term HMV children need assessment, planning, and resources. A wide variability in pattern of HMV was found throughout Italy. An Italian national ventilation program, as well as a national registry, could be useful in improving the care of these often critically ill children.


Assuntos
Serviços de Assistência Domiciliar/estatística & dados numéricos , Respiração Artificial/estatística & dados numéricos , Insuficiência Respiratória/terapia , Adolescente , Distribuição por Idade , Criança , Pré-Escolar , Demografia , Feminino , Serviços de Assistência Domiciliar/normas , Visita Domiciliar/estatística & dados numéricos , Humanos , Itália , Masculino , Monitorização Fisiológica , Alta do Paciente/estatística & dados numéricos , Respiração Artificial/normas , Insuficiência Respiratória/etiologia , Inquéritos e Questionários , Fatores de Tempo
13.
Br J Pharmacol ; 162(4): 792-805, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21039422

RESUMO

Therapy-related myeloid neoplasms (t-MNs) are serious long-term consequences of cytotoxic treatments for an antecedent disorder. t-MNs are observed after ionizing radiation as well as conventional chemotherapy including alkylating agents, topoisomerase-II-inhibitors and antimetabolites. In addition, adjuvant use of recombinant human granulocyte-colony stimulating factor may also increase the risk of t-MNs. There is clinical and biological overlap between t-MNs and high-risk de novo myelodysplastic syndromes and acute myeloid leukaemia suggesting similar mechanisms of leukaemogenesis. Human studies and animal models point to a prominent role of genetic susceptibilty in the pathogenesis of t-MNs. Common genetic variants have been identified that modulate t-MN risk, and t-MNs have been observed in some cancer predisposition syndromes. In either case, establishing a leukaemic phenotype requires acquisition of somatic mutations - most likely induced by the cytotoxic treatment. Knowledge of the specific nature of the initiating exposure has allowed the identification of crucial pathogenetic mechanisms and for these to be modelled in vitro and in vivo. Prognosis of patients with t-MNs is dismal and at present, the only curative approach for the majority of these individuals is haematopoietic stem cell transplantation, which is characterized by high transplant-related mortality rates. Novel transplantation strategies using reduced intensity conditioning regimens as well as novel drugs - demethylating agents and targeted therapies - await clinical testing and may improve outcome. Ultimately, individual assessment of genetic risk factors may translate into tailored therapies and establish a strategy for reducing t-MN incidences without jeopardizing therapeutic success rates for the primary disorders.


Assuntos
Leucemia Mieloide Aguda , Síndromes Mielodisplásicas , Segunda Neoplasia Primária , Animais , Antineoplásicos/efeitos adversos , Predisposição Genética para Doença , Transplante de Células-Tronco Hematopoéticas , Humanos , Leucemia Mieloide Aguda/induzido quimicamente , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/fisiopatologia , Leucemia Mieloide Aguda/terapia , Síndromes Mielodisplásicas/induzido quimicamente , Síndromes Mielodisplásicas/genética , Síndromes Mielodisplásicas/fisiopatologia , Síndromes Mielodisplásicas/terapia , Segunda Neoplasia Primária/induzido quimicamente , Segunda Neoplasia Primária/genética , Segunda Neoplasia Primária/fisiopatologia , Segunda Neoplasia Primária/terapia , Prognóstico , Radioterapia/efeitos adversos
14.
Minerva Anestesiol ; 76(5): 340-5, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20395896

RESUMO

AIM: Fetal heart rate (FHR) changes have been reported after regional labor analgesia. In this prospective single-blinded study, we aimed to assess whether epidural analgesia with ropivacaine and sufentanil is associated with significant changes in fetal heart rate. METHODS: Fetal heart rate traces from 120 women in active labor requesting epidural analgesia were recorded and analyzed by two reviewers 90 minutes before and after epidural analgesia for baseline fetal heart rate, accelerations, decelerations and long-term variability. RESULTS: A significantly decreased number of fetal heart rate accelerations (ANOVA P=0.0001) and a higher percentage of segments with decelerations (P<0.05) were observed in the three segments after analgesia as compared to the three preceding segments. The minimum number of accelerations occurred during the 30 minutes immediately after analgesia was initiated. The reviewers were concordant in finding a significant change from the 60 minutes before to the 60 minutes after analgesia, a period in which there CONCLUSION: Epidural analgesia with ropivacaine and sufentanil is associated with fetal heart rate changes. These modifications are transient and should be considered when evaluating fetal heart rate monitoring during labor to prevent inappropriate obstetric management decisions to proceed with operative labor.


Assuntos
Amidas/efeitos adversos , Analgésicos Opioides/administração & dosagem , Anestesia Epidural/efeitos adversos , Anestesia Obstétrica/efeitos adversos , Anestésicos Locais/efeitos adversos , Frequência Cardíaca Fetal/efeitos dos fármacos , Sufentanil/efeitos adversos , Adulto , Feminino , Humanos , Trabalho de Parto/efeitos dos fármacos , Gravidez , Estudos Prospectivos , Ropivacaina , Método Simples-Cego , Adulto Jovem
15.
Minerva Anestesiol ; 71(6): 373-8, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15886604

RESUMO

AIM: Protein C (PC) is a plasma glycoprotein implicated in modulating coagulation and inflammation. Its levels decrease in sepsis and related diseases, where it has also proved to be a prognostic indicator of outcome. Infusion of exogenous PC, although not able to decrease mortality in severe sepsis and septic shock, can safely resolve the coagulation imbalances related to these pathological states. METHODS: A retrospective study was performed about utilisation of PC in severe sepsis and septic shock patients in three italian PICUs during a one-year period. Data from 29 patients were analysed. Age, PIM 2, mortality and length of stay were compared between treated and non treated patients. Treated patients were also analysed for PC dosage received, length of treatment, and modification of hemocoagulation parameters, before PC infusion and every 24 hours. RESULTS: In treated patients, the activity of PC, PT and PTT activity and fibrinogen improved significantly from basal to day 5 (p<0.05). Diminution of d-dimer was not quite significant (p=0.0514). Rise in platelets count and antithrombin III activity was not significant. No adverse reactions related to Protein C concentrate were observed. No difference in mortality was observed between the two groups. CONCLUSIONS: Although PC is included in guidelines for management of severe sepsis and septic shock, only 38%, of observed patients received PC treatment. Even in the treated group, patients received a lower dosage of PC, and for a shorter period, than recommended. In accordance to previous studies, we did not observe differences in mortality between treated and untreated patients. Our results showed a significant increase in plasma PC activity, following infusion of PC concentrate. This increase in PC appeared sufficient to restore some, but not all, of the abnormalities in the coagulation system. A large randomized, phase 3, placebo-controlled trial in children with severe sepsis and septic shock is advisable to establish effective role of therapy with PC in reducing mortality of these patients.


Assuntos
Anticoagulantes/uso terapêutico , Proteína C/uso terapêutico , Sepse/sangue , Sepse/tratamento farmacológico , Testes de Coagulação Sanguínea , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Proteínas Recombinantes/uso terapêutico , Estudos Retrospectivos , Choque Séptico/tratamento farmacológico
16.
J Clin Microbiol ; 42(10): 4835-7, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15472355

RESUMO

For febrile neutropenic patients who received hematopoietic stem cell transplantation, the Gram stain-acridine orange leukocyte cytospin (AOLC) test and the differential-time-to-positivity method (DTP) were performed. As a diagnostic tool for catheter-related bloodstream infections in these patients, the Gram stain-AOLC test has a lower sensitivity than does the DTP method but acceptable positive and negative predictive values.


Assuntos
Bacteriemia/diagnóstico , Cateterismo Venoso Central/efeitos adversos , Cateteres de Demora/efeitos adversos , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Neutropenia/terapia , Laranja de Acridina , Bacteriemia/microbiologia , Técnicas Bacteriológicas , Contaminação de Equipamentos , Corantes Fluorescentes , Violeta Genciana , Humanos , Leucócitos , Fenazinas , Coloração e Rotulagem , Fatores de Tempo
17.
Eur J Clin Microbiol Infect Dis ; 22(12): 760-3, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14605936

RESUMO

In order to determine whether a blood culture positive for coagulase-negative staphylococci (CNS) represents bacteremia or contamination, a prospective study was conducted using molecular typing to analyze CNS blood culture isolates and corresponding CNS skin isolates collected after skin disinfection from 431 subjects. CNS bacteremia was not found in any of the 301 subjects not suspected of having bacteremia. In 130 patients suspected of having bacteremia, the rate of actual CNS bacteremia was 6%. The overall rate of CNS blood culture contamination was 1%. Chart analysis showed good agreement between our microbiological definitions of bacteremia and the clinical definitions previously published. Bacteremia and contamination can be differentiated using pulsed-field gel electrophoresis and molecular typing of CNS isolates obtained from cultures of blood and corresponding skin samples.


Assuntos
Bacteriemia/microbiologia , Sangue/microbiologia , Pele/microbiologia , Infecções Estafilocócicas/microbiologia , Staphylococcus/classificação , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Bacteriemia/sangue , Técnicas de Tipagem Bacteriana , Coagulase/metabolismo , Estudos de Coortes , Diagnóstico Diferencial , Eletroforese em Gel de Campo Pulsado/métodos , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Medição de Risco , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Distribuição por Sexo , Infecções Estafilocócicas/sangue
18.
J Neuroimmunol ; 120(1-2): 50-7, 2001 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-11694319

RESUMO

We have previously shown in the rat model that acutely or chronically increased peripheral catecholamines lead to suppression of lymphocyte responsiveness via alpha(2)-adrenoceptor activation. Here we investigated the effects of alpha-adrenergic treatment on total leukocyte numbers and proportions of leukocyte subsets in peripheral blood and lymphoid tissues. It was found that a 12-h treatment with subcutaneously implanted tablets, one containing norepinephrine (NE) and one propranolol, leads to an increase in total blood leukocyte counts, due to a pronounced increase in granulocytes. In contrast, the numbers of all classes of lymphocytes other than NK cells were decreased. This decrease in blood lymphocytes is apparently not due to redistribution, since in the thymus, spleen, mesenteric and peripheral lymph nodes, the total numbers of lymphocytes were decreased as well, without any changes in subpopulations. Analogous results were obtained with rats adrenalectomized before the catecholamine treatment. Animals that received the alpha-adrenergic treatment displayed significantly more apoptotic cells in the lymphoid organs, as determined by the TUNEL technique. In the spleen, the enhanced rate of apoptosis was confined to the white pulp; red pulp areas exhibited significantly fewer apoptotic cells. Thus, an increased alpha-adrenergic tone in rats led to a general loss of lymphocytes due to lymphocyte directed apoptosis that was independent of glucocorticoids.


Assuntos
Apoptose/efeitos dos fármacos , Catecolaminas/imunologia , Divisão Celular/efeitos dos fármacos , Granulócitos/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Neuroimunomodulação/efeitos dos fármacos , Receptores Adrenérgicos alfa/imunologia , Medula Suprarrenal/imunologia , Medula Suprarrenal/metabolismo , Antagonistas Adrenérgicos beta/farmacologia , Animais , Apoptose/imunologia , Catecolaminas/metabolismo , Divisão Celular/imunologia , Granulócitos/citologia , Granulócitos/imunologia , Contagem de Leucócitos , Linfócitos/citologia , Linfócitos/imunologia , Tecido Linfoide/citologia , Tecido Linfoide/efeitos dos fármacos , Tecido Linfoide/imunologia , Masculino , Neuroimunomodulação/fisiologia , Norepinefrina/farmacologia , Propranolol/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos alfa/efeitos dos fármacos , Receptores Adrenérgicos alfa/metabolismo , Fibras Simpáticas Pós-Ganglionares/imunologia , Fibras Simpáticas Pós-Ganglionares/metabolismo
19.
FEBS Lett ; 502(3): 127-31, 2001 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-11583113

RESUMO

The antioxidant activity of melatonin (MEL) has been considered to constitute part of its physiological as well as pharmacological effects. However, as described herein we found a profound prooxidant activity of micro- to millimolar concentrations of MEL in the human leukemic Jurkat cell line. This prooxidant effect was increased in glutathione-depleted cells and counteracted by antioxidants. As a consequence MEL promoted fas-induced cell death. These data therefore indicate that MEL may be a modulator of the cellular redox status, but does not necessarily act as an intracellular antioxidant.


Assuntos
Antioxidantes/farmacologia , Apoptose/efeitos dos fármacos , Células Jurkat/patologia , Melatonina/farmacologia , Receptor fas/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Glutationa/metabolismo , Humanos , Peróxido de Hidrogênio/farmacologia , Indicadores e Reagentes , Células Jurkat/metabolismo , Oxidantes/farmacologia , Oxirredução , Espécies Reativas de Oxigênio/metabolismo , Rodaminas
20.
Respir Physiol ; 126(3): 211-9, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11403783

RESUMO

An index (IS), quantitating the departure of the inspiratory flow profile (IFP) from the rectangular one, i.e. the optimal profile (IS=0), was computed from pneumotachograms recorded in 26 normal, anesthetized subjects breathing spontaneously through the endotracheal tube (ETT) or face mask (FM) with or without added resistances (R) and in 27 awake subjects breathing through the mouth and FM in the supine and seated posture at rest and during exercise (40 W) on a cycloergometer, through the nose and FM, and through the mouthpiece (MP). During anesthesia, IS decreased with R both while breathing through the ETT (DeltaIS=-0.037+/-0.006 (SE); P<0.001) and FM (DeltaIS=-0.054+/-0.008; P<0.001). This indicates that (a) the change of IFP towards the optimal shape is reflex in nature and related to the dynamic inspiratory load, and (b) tracheobronchial mechanoreceptors and inspiratory muscles are involved in this response. The reflex is also operative in awake subjects, since IS decreased whenever the inspiratory dynamic load was increased, as on turning from seated to supine posture (DeltaIS=-0.024+/-0.003; P<0.001), shifting from mouth to nose breathing (DeltaIS=-0.034+/-0.003; P<0.05), from rest to mild exercise (DeltaIS=-0.066+/-0.005; P<0.001). The different IS value between FM and MP breathing (DeltaIS=0.036+/-0.004; P<0.001) indicates, however, that other factors, likely behavioral, also affect the IFP.


Assuntos
Ventilação Pulmonar/fisiologia , Adulto , Resistência das Vias Respiratórias , Anestesia , Ciclismo , Feminino , Humanos , Intubação Intratraqueal , Masculino , Máscaras , Respiração Bucal , Cavidade Nasal/fisiologia , Postura/fisiologia , Decúbito Dorsal , Vigília
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...